Latest filing published 28 Sept 2015 for Vaxart, Inc., €4,227.
Insider track record
No signal scores available.
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -2.5%Entry US$21.78 · Close at T+365 US$21.23
- -32.3%Entry US$25.85 · Close at T+365 US$17.49
- -31.2%Entry US$33.11 · Close at T+365 US$22.77
- -30.7%Entry US$33.33 · Close at T+365 US$23.10
- -36.7%Entry US$35.64 · Close at T+365 US$22.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joseph M. Patti: trading record in brief
Filings by Joseph M. Patti span 2 companies, the busiest being Inhibitex Inc and Vaxart, Inc. We count 24 filings; the first trade dates from 10 January 2006 and the latest from 25 September 2015.
On the open market, the record shows 12 purchases worth €113k and 6 sales worth €2.0M. Sales outweigh purchases by €1.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants and 2 option exercises. In 2015 alone, the filings show 4 purchases and no sales.
A typical purchase (the median) is worth €5,973. For 11 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -18.5%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 28 September 2015, reports an open-market purchase of €4,227 in Vaxart, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph M. Patti
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$1.89Common stockSEC:0001437749-15-017766:0Canonical exit: 24 Dec 2015 (T+90)
- 2,500 shares@ US$1.85Common stockSEC:0001437749-15-017766:1Canonical exit: 24 Dec 2015 (T+90)
- 10,000 shares@ US$2.27Common stockSEC:0001437749-15-006450:0Canonical exit: 25 Jun 2015 (T+90)
- 10,000 shares@ US$2.30Common stockSEC:0001437749-15-006450:1Canonical exit: 25 Jun 2015 (T+90)
- 10,000 shares@ US$2.86Common StockSEC:0001209191-14-044978:0Canonical exit: 28 Sept 2014 (T+90)
- 4,200 shares@ US$2.81Common StockSEC:0001209191-14-044367:0Canonical exit: 25 Sept 2014 (T+90)
- 800 shares@ US$2.78Common StockliSEC:0001209191-14-044367:1Canonical exit: 25 Sept 2014 (T+90)
- 8,451 shares@ US$2.45Common StockSEC:0001209191-14-040906:0Canonical exit: 8 Sept 2014 (T+90)
- 400 shares@ US$2.62Common StockSEC:0001209191-14-040906:1Canonical exit: 8 Sept 2014 (T+90)
- 2,995 shares@ US$2.80Common StockSEC:0001209191-14-040906:2Canonical exit: 9 Sept 2014 (T+90)
- 2,621 shares@ US$2.97Common StockSEC:0001209191-14-040906:3Canonical exit: 9 Sept 2014 (T+90)
- 71,661 shares0Common StockSEC:0001209191-12-053094:0
- 174,596 shares@ US$7.79Common StockSEC:0001209191-11-054959:0
- 35,000 shares@ US$8.00Common StockSEC:0001209191-11-054959:1
- 12,606 shares@ US$2.64Common StockSEC:0001209191-11-000976:0
- 22,655 shares@ US$1.67Common StockSEC:0001209191-10-022968:0
- 20,000 shares@ US$0.22Common StockSEC:0001209191-08-060911:0Canonical exit: 12 Feb 2009 (T+90)
- 18,254 shares@ US$0.66Common StockSEC:0001209191-08-025966:0
- 22,869 shares@ US$1.58Restricted StockSEC:0001209191-06-049547:0
- 80,120 shares@ US$2.05Restricted StockSEC:0001209191-06-026169:0
- 35,000 shares@ US$9.04Common StockSEC:0001209191-06-003899:0
- 12,350 shares@ US$9.01Common StockSEC:0001209191-06-003484:0
- 30,000 shares@ US$9.05Common StockSEC:0001209191-06-003484:1
- 27,650 shares@ US$9.00Common StockSEC:0001209191-06-003093:0
24 of 24 declarations
